icon-    folder.gif   Conference Reports for NATAP  
 
  Conference on Retroviruses
and Opportunistic Infections (CROI)
February 22-25, 2016, Boston MA
Back grey_arrow_rt.gif
 
 
 
Resistance Associated Variants: Data From the NIAID SYNERGY Trial
/ Harvoni-Retreating Short Duration Therapy
 
 
  Reported by Jules Levin
CROI 2016 Feb 22-24 Boston
 
Eleanor M. Wilson1; Sarah Kattakuzhy2; Hongmei Mo3; Anuoluwapo Osinusi3; Henry Masur4; Anita Kohli5; Shyam Kottilil6
1Inst of Human Virology, Baltimore, MD, USA; 2Inst of Human Virology, Bethesda, MD, USA; 3Gilead Scis, Inc, Foster City, CA, USA; 4NIH, Bethesda,
MD, USA; 5Dignity Hlth, St. Joseph’s Hosp, Phoenix, AZ, USA; 6Univ of Maryland Med Cntr, Baltimore, MD, USA

CROI1

CROI2

CROI3

CROI4